Key Findings:  The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and portend to revolutionize neurological treatment into a new reality of effective interventional and even preventative treatment.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Czech Republic
Year of Pub:  2018
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabidiolic Acid (CBD-a), Tetrahydrocannabinolic Acid (THC-a)
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene, Limonene, Linalool, Pinene
Receptors Studied:  CB1, CB2, PPAR - Gamma, TRPs
Ligands Studied:  Serotonin
Citation:  Russo EB. Cannabis Therapeutics and the Future of Neurology. Front Integr Neurosci. 2018; 12:51. doi: 10.3389/fnint.2018.00051
Authors:  Russo EB